Such measures include soluble triggering receptor expressed on myeloid cells 2 (TREM2), which has been extensively investigated in Alzheimer's disease (AD),7, 8, 9 and the chitinases. The gene discussed is TREM2; the disease is early-onset autosomal dominant Alzheimer disease.